BridgeBio Pharma (BBIO) has priced its private offering of $550M aggregate principal amount of 0.75% convertible senior notes ...

SAINT HELIER, JE / ACCESS Newswire / January 14, 2026 / Caledonia Mining Corporation Plc ("Caledonia"), a gold production, exploration and development company, today announced its intention to offer ...

Arrowhead Pharmaceuticals (ARWR) announced its public offerings, pricing $625M of 0.00% convertible senior notes due in 2032 and 3.1M shares of common stock at $64.50 per share. Instead of common ...

The transaction is part of our strategy to lower interest expense, reduce dilution, and significantly extend debt ...

Transaction to Increase Solana Treasury by 12% to over 2.4 million SOLOffering is Accretive to Adjusted Solana per Share upon ConversionTAMPA, ...

Investing.com -- BridgeBio Pharma has priced a private offering of $550 million in convertible senior notes due 2033, with a 0.75% interest rate and a 45% conversion premium.

On Jan. 7, 2026, investors weighed a massive notes deal, raised guidance, and an approved merger reshaping this real estate ...

Full conversion of convertible notes reduces long-term liabilities, removes potential equity overhang, and helps ...

FuboTV has announced the repurchase of $140.2 million (€120.4m) aggregate principal amount of its outstanding 3.25 per cent ...

Calgary, Alberta / October 15, 2025 –TheNewswire -Credissential Inc. (“Credissential” or the “Company”) (CSE: WHIP), a vertically integrated AI software development companyis pleased to announce a non ...